Skip to content

A Functional Pain Scale to Improve the Patient Experience

A Pilot Study to Validate a Functional Pain Scale in Order to Improve the Patient Experience

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04124289
Enrollment
49
Registered
2019-10-11
Start date
2019-10-29
Completion date
2020-07-02
Last updated
2023-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Measurement

Brief summary

This will be an observational cohort study to evaluate pain measurement after surgery using a new functional pain scale.

Detailed description

Patients admitted for orthopedic surgery may take part in this research. Participants will be assessed using three different pain scales: numeric rating scale (NRS), FACES pain scale and a new functional pain scale (FPS).

Interventions

OTHERPain measurement using 3 scales

Patients will assess their pain after surgery using three different pain scales.

Sponsors

The Guthrie Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Completed orthopedic (hip or knee) surgery * English as primary language and able to read * Low risk as assessed by Opioid Risk Assessment Tool (ORAT) * No history of opioid abuse * Patients with a diagnosis of chronic pain other than the scheduled hip or knee meeting the above criteria may be included.

Exclusion criteria

* Previous diagnosis of cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Change in pain score using functional pain scale questionnaireThrough study completion, an average of 4 days.Change in pain measurement using new functional pain scale from baseline postoperatively until discharge. The functional pain scale is a scale of 10 descriptive words related to pain and ability to function, ranging from minimal to immobilizing
Change in pain score using FACES pain scaleThrough study completion, an average of 4 days.Change in pain measurement using FACES pain scale from baseline postoperatively until discharge. The scale includes pictures of facial expressions with correlating numerical scale of 0-10, 0 being no hurt and 10 being the worst hurt.
Change in pain score using numeric 0-10 rating scaleThrough study completion, an average of 4 days.Change in pain measurement using standard numeric rating scale from baseline postoperatively until discharge. The numeric rating scale is 0-10 where 0 is no pain, 5 is moderate pain and 10 is the worst pain.
Change in functionalityThrough study completion, an average of 4 days.Change in patient's ability to complete daily functions from baseline postoperatively until discharge. Physical therapy and occupational therapy reports will be reviewed to see if pain appears to interfere with the ability to participate in rehabilitation therapy.

Secondary

MeasureTime frameDescription
Provider preference for ease of use of the three pain scales (functional, FACES or numerical)Through study completion, an average of 4 days.Questionnaire: Provider will be asked to answer one question regarding which of the three pain scales they found easiest to complete. On a scale of 1 to 3 with 1 being the best for ease of use, the provider will choose which pain scale they would rank a 1.
Opioid administrationThrough study completion, an average of 4 daysDose of opioid administered postoperatively during the hospital stay
Patient preference for ease of use of the three pain scales (functional, FACES or numerical)Through study completion, an average of 4 days.Questionnaire: Patient will be asked to answer one question to choose which of the three pain scales they prefer for reporting their level of pain. On a scale of 1 to 3 with 1 being the best for reporting pain, the patient will choose which pain scale they would rank a 1.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026